Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism

Kidney International

Volumn 57, Issue 4, 2000, Pages 1675-1680

  Wang, Andrew ^a   Holcslaw, Terry ^a   Bashore, Thomas M ^a   Freed, Martin I ^a   Miller, Diane ^a   Rudnick, Michael R ^a   Szerlip, Harold ^a   Thames, Marc D ^a   Davidson, Charles J ^a   Shusterman, Neil ^a   Schwab, Steven J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac angiography; Endothelin; Nephrotoxic radiocontrast medium; Receptor; Renal failure

Indexed keywords

CONTRAST MEDIUM; CREATININE; DYE; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; SB 290670;

ADULT; AGED; ANGIOCARDIOGRAPHY; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPOTENSION; KIDNEY BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034115616     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00012.x     Document Type: Conference Paper

References (28)

1. 1. D'ELIA JA, GLEASON RE, ALDAY M, MALARICK C, GODLEY K, WARRAM J, KALDANY A, WEINRAUCH LA: Nephrotoxicity from angiographic contrast material: A prospective study. Am J Med 72:719-725, 1982
2. 2. HOU SH, BUSHINSKY DA, WISH JB, COHEN JJ, HARRINGTON JT: Hospital-acquired renal insufficiency: A prospective study. Am J Med 74:243-248, 1983
3. 3. SHUSTERMAN N, STROM BL, MURRAY TG, MORRISON G, WEST SL, MAISLIN G: Risk factors and outcome of hospital-acquired acute renal failure: Clinical epidemiologic study. Am J Med 83:65-71, 1987
4. 4. LEVY EM, VISCOLI CM, HORWITZ RI: The effect of acute renal failure on mortality: A cohort analysis. JAMA 275:1489-1494, 1996
5. 5. HEYMAN SN, BREZIS M, EPSTEIN FH, SPOKES K, SILVA P, ROSEN S: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 40:632-642, 1991
6. 6. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T: Endothelin: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
7. 7. MILLER WL, REDFIELD MM, BURNETT JC JR: Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 83:317-320, 1989
8. 8. MARGULIES KB, HILDEBRAND FL, HEUBLEIN DM, BUKNETT JC JR: Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 2:1041-1045, 1991
9. 9. CANTLEY LG, SPOKES K, CLARK B, MCMAHON EG, CARTER J, EPSTEIN FH: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 44:1217-1223, 1993
10. 10. BROOKS DP, DEPALMA PD: Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670. Nephron 72:629-636, 1996
11. 11. VAN ZEE BE, HOY WE, TALLEY TE, JAENIKE JR: Renal injury associated with intravenous pyelography in nondiabetic and diabetic patients. Ann Intern Med 89:51-54, 1978
12. 12. KUMAR S, HULL JD, LATHI S, COHEN AJ, PLETKA PG: Low incidence of renal failure after angiography. Arch Intern Med 141:1268-1170, 1981
13. 13. MASON RA, ARBEIL LA, GIRON F: Renal dysfunction after adenography. JAMA 253:1001-1004, 1985
14. 14. PARFREY PS, GRIFFITHS SM, BARRETT BJ, PAUL MD, GENGE M, WITHERS J, FARID N, MCMANAMON PJ: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: A prospective controlled study. N Engl J Med 320:143-149, 1989
15. 15. SOLOMON R, WERNER C, MANN D, D'ELIA J, SILVA P: Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420, 1994
16. 16. SCHWAB SJ, HLATKY MA, PIEPER KS, DAVIDSON CJ, MORRIS KG, SKELTON TN, BASHORE TM: Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320:149-153, 1989
17. 17. RUDNICK MR, GOLDFARB S, WEXLER L, LUDBROOK PA, MURPHY MJ, HALPERN EF, HILL JA, WINNIFORD M, COHEN MB, VANFOSSEN DB: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. Kidney Int 47:254-261, 1995
18. 18. ARAI H, HORI S, ARAMORI I, OHKUBO H, NAKANISHI S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732, 1990
19. 19. SAKURAI T, YANAGISAWA M, TAKUWA Y, MIYAZAKI H, KIMURA S, GOTO K, MASAKI T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735, 1990
20. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89:1203-1208, 1994
21. 21. FOGO A, HILLINGS SE, INAGAMI T, KON V: Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 43:770-774, 1992
22. 22. KIVLIGHN SD, GABEI RA, SIEGI PKS: Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. Kidney Int 45:131-136, 1994
23. 23. NAMBI P, WU H-L, PULLEN M, ELSHOURBAGY N, OHSTEIN EH, BROOKS DP, ELLIOTT JD, GLEASON J, RUFFOLO RR JR: Non-peptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human ET and ET receptors. J Pharmacol Exp Ther 271:755-761, 1994
24. 24. WEBER C, SCHMITT R, BIRNHOECK H, HOPEGARTNER G, VAN MARLE SP, PEETERS PAM, JONKMAN JHG, JONES CR: Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects. Clin Pharmacol Ther 60:124-137, 1996
25. 25. RUSSO D, TESTA A, DELLA VOLPE L, SANSONE G: Randomised prospective study on renal effects of two different contrast media in humans: Protective role of a calcium channel blocker. Nephron 55:254-257, 1990
26. 26. NEUMAYER H-H, JUNGE W, KUTNER A, WENNING A: Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomised clinical trial. Nephrol Dial Transplant 4:1030-1036, 1989
27. 27. WEISBERG LS, KURNIK PB, KURNIK BRC: Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren Fail 15:61-68, 1993
28. 28. WEISBERG LS, KURNIK PB, KURNIK BRC: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45:259-265, 1994